Recursion Venture Capital

The firm applies recursive, data-driven analytical frameworks — conceptually similar to those used in computational biology and drug discovery — to identify early-stage technology and life sciences startups. The thesis hinges on the belief that systematic pattern recognition across large, structured data sets can surface high-potential companies before they become visible in conventional venture pipelines. This approach prioritizes founders building defensible data assets and intellectual property moats.

The firm operates from four offices: Seattle and Bellevue in Washington state, and San Francisco and Palo Alto in California. This dual-hub footprint spans the Pacific Northwest technology corridor and Silicon Valley, giving the firm exposure to distinct talent pools in cloud infrastructure, artificial intelligence, biotechnology, and enterprise software.

The primary structural differentiator is its application of computational-biology frameworks to investment decision-making — a systematic, algorithmic approach to sourcing and evaluation that more closely resembles quantitative hedge fund operations than conventional venture capital. The firm's name, 'Recursion,' signals an iterative, self-reinforcing analytical process designed to industrialize early-stage discovery without sacrificing high-conviction portfolio construction.

The firm has not publicly identified its leadership team, investment committee members, or general partners through its website, LinkedIn, or other official channels. No named principals can be confirmed through primary sources as of the latest available records.